Technical Analysis for SVA - Sernova Corp.

Grade Last Price % Change Price Change
F 0.250 0.00% 0.000
SVA closed unchanged on Friday, November 1, 2024, on 27 percent of normal volume. It ran into resistance at its 50 day moving average.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
50 DMA Resistance Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Gapped Up Strength 0.00%
Fell Below 20 DMA Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
180 Bearish Setup Bearish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Sernova Corp. Description

Sernova Corp. is a development-stage regenerative medicine company. The Company is engaged in the development of its Cell Pouch and associated technologies, including therapeutic cells for the treatment of chronic diseases and local immune protection technologies. It is focused on developing a treatment for insulin-dependent human diabetes and other metabolic, blood and neurological diseases with therapeutic cells placed into its implanted and prevascularized medical device (the Cell Pouch), protected from immune system attack. The Cell Pouch is designed to create a microvessel rich, tissue environment for the transplantation and engraftment of therapeutic cells, which then release proteins and/or hormones for the treatment of chronic diseases, such as diabetes and thyroid disease. Its lead program is the clinical development of the Cell Pouch for treatment of patients with insulin dependent diabetes. It is also evaluating Cell Pouch for the treatment of patients with hemophilia A.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Clinic Disease Emerging Technologies RTT Biology Diseases Diabetes Plantation Proteins Regenerative Medicine Immune System Neurological Diseases Stem Cells Diabetes Mellitus Graft Hormone Insulin Transplantation

Is SVA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.82
52 Week Low 0.2
Average Volume 214,831
200-Day Moving Average 0.398
50-Day Moving Average 0.254
20-Day Moving Average 0.254
10-Day Moving Average 0.254
Average True Range 0.016
RSI (14) 48.98
ADX 13.52
+DI 21.285
-DI 22.356
Chandelier Exit (Long, 3 ATRs) 0.232
Chandelier Exit (Short, 3 ATRs) 0.273
Upper Bollinger Bands 0.276
Lower Bollinger Band 0.232
Percent B (%b) 0.41
BandWidth 17.100
MACD Line -0.003
MACD Signal Line -0.002
MACD Histogram -0.0008
Fundamentals Value
Market Cap 52.07 Million
Num Shares 208 Million
EPS -0.02
Price-to-Earnings (P/E) Ratio -13.16
Price-to-Sales 0.00
Price-to-Book 38.62
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.265
Resistance 3 (R3) 0.267 0.263 0.263
Resistance 2 (R2) 0.263 0.260 0.263 0.262
Resistance 1 (R1) 0.257 0.257 0.255 0.255 0.261
Pivot Point 0.253 0.253 0.253 0.253 0.253
Support 1 (S1) 0.247 0.250 0.245 0.245 0.239
Support 2 (S2) 0.243 0.247 0.243 0.238
Support 3 (S3) 0.237 0.243 0.238
Support 4 (S4) 0.235